- Issuer ticker
-
ELAN
- Reported as of
-
01 Mar 2026
- Net transaction value
-
-$1,221,739
- SEC form
-
4
- Accepted by SEC
-
03 Mar 2026, 19:14:47 UTC
Filing notes and source
Key filing fact
Ellen de Brabander filed Form 4 for Elanco Animal Health Inc (ELAN) on 03 Mar 2026.
Key facts
- This page summarizes Ellen de Brabander's Form 4 filing for Elanco Animal Health Inc (ELAN).
- 4 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 03 Mar 2026, 19:14.
Change
- Previous filing in this sequence was filed on 06 Jan 2026.
- Current net transaction value: -$1,221,739.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001892179
Primary reporting owner
de Brabander Ellen
- Relationship
-
Executive Vice President, Research, Development and Regulatory Affairs
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ELAN
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +67,564
- Change %
- +30%
- Price
-
$0.000000
- Shares after
- 289,304
- Date
- 01 Mar 2026
- Ownership
- Direct
ELAN
transaction
Common Stock
Tax liability
- Transaction value
- -$1,221,739
- Shares
- -46,278
- Change %
- -16%
- Price
-
$26.40
- Shares after
- 243,026
- Date
- 01 Mar 2026
- Ownership
- Direct
ELAN
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +25,360
- Change %
- +10%
- Price
-
$0.000000
- Shares after
- 268,386
- Date
- 01 Mar 2026
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ELAN
transaction
Derivative
Employee Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +51,819
- Change %
- Price
-
$0.000000
- Shares after
- 51,819
- Date
- 01 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 51,819
- Exercise price
- $26.40
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Explanation of responses
2 footnotes
SEC remarks
Executive Vice President, Research, Development and Regulatory Affairs